Phase III Randomised Study on Liposomal Cytarabine (DepoCyte) vs. Intrathecal Triple for CNS-Treatment During Maintenance Therapy in High-Risk Acute Lymphoblastic Leukemia Patients in NOPHO ALL 2008 Treatment Protocol.
Phase of Trial: Phase III
Latest Information Update: 02 May 2016
At a glance
- Drugs Cytarabine (Primary) ; Asparaginase; Dexamethasone; Mercaptopurine; Methotrexate; Prednisolone sodium succinate
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 02 May 2016 This trial is 'prematurely ended' in Lithuania, according to European Clinical Trials Database.
- 17 Mar 2012 Additional location (Lithuania) added and additional lead trial centre identified as reported by European Clinical Trials Database record.
- 20 Oct 2009 New trial record